BioSpace News Archive

Drug Development

COVID-19 News Update: Moderna Files for EUA in Adolescents and More

Although the COVID-19 pandemic is waning in the U.S., there is still plenty of research and news about the disease. Here’s a look.

June 10, 2021
·
5 min read
·
Mark Terry
Business

Three Biopharma Companies Close Series A Financing Rounds

June appears to be a busy month for Series A financing rounds, with Kurome, Onchilles Pharma, and Hawthorne Effect closing in on millions of dollars worth of startup investments.

June 10, 2021
·
3 min read
·
Brandon May
Business

Report: Investors Urge Ouster of Regeneron Director Over Executive Compensation

Two of the company’s largest shareholders call for the ouster of a company director at Regeneron as top executives are under fire for their enormous compensation packages.

June 10, 2021
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, June 11

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

June 10, 2021
·
9 min read
·
Alex Keown
Drug Development

South African HIV Patient Was a Natural Laboratory for SARS-CoV-2 Mutations

An immunocompromised patient in South Africa became a veritable COVID-19 variant laboratory as the virus mutated more than 30 times in 216 days of her infection, according to recent, not-yet-peer-reviewed research paper published in medRxiv.

June 10, 2021
·
4 min read
·
Gail Dutton
Drug Development

Are Vindictive Variants Threatening Our COVID-19 Recovery?

According to the CDC, the Delta variant now accounts for more than 6% of infections in the U.S. and may be responsible for 18% of cases in some Western states.

June 10, 2021
·
5 min read
·
Heather McKenzie
Growth Mindset Examples, Definition, and How You Can Use It In Your Job

Developing your knowledge, learning new things, adapting to changes handling criticism, and fighting insecuritiesare a few growth mindset examples and definitions.

June 10, 2021
·
4 min read
·
Lorenzo Soliman
Drug Development

Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate

Valneva SE announced that it has completed recruitment for the clinical lot-to-lot consistency Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553.

June 10, 2021
·
7 min read
Drug Development

ObsEva Presents PROLONG Phase 2a Proof-of-Concept Data on Ebopiprant (OBE022) for the Treatment of Spontaneous Preterm Labor at the RCOG Virtual World Congress 2021

ObsEva SA announced the presentation of clinical data from the PROLONG Phase 2a proof-of-concept study of ebopiprant for the treatment of spontaneous preterm labor at the Royal College of Obstetricians and Gynecologists Virtual World Congress 2021.

June 10, 2021
·
8 min read
Drug Development

OXURION Confirms Institutional Review Board Approval and Submission of the Investigational New Drug Application to the FDA to Start Phase 2 Study Evaluating THR-687 for Diabetic Macular Edema (DME)

Oxurion NV announces that it has received Institutional Review Board approval to initiate a Phase 2 clinical study of THR-687 in patients with Diabetic Macular Edema.

June 10, 2021
·
5 min read